Perlman Syndrome – Definition

Perlman syndrome (OMIM #267000) is a rare, recessive macrosomia syndrome characterized by hydramnios, renal dysplasia, and characteristic facial dysmorphia.

Synonyms:

Nephroblastomatosis, fetal ascites, macrosomia, and Wilms tumor

Gene:

DIS3L2

Gen­e product:

DIS3L2

Function:

Role in the degradation of miRNA

Pattern of inheritance:

Autosomal recessive

Prevalence:

Extremely rare

Genotype-phenotype correlation

Unknown

Penetrance:

Unknown

Overview of the Chapters on This Page:

  • Clinical Presentation

  • Special Features of Treatment

  • Recommendations for Early Detection in Your Patients
  • Further Information (e.g., Links to Support Groups)

  • Clinical Presentation

  • Special Features of Treatment

  • Recommendations for Early Detection in Your Patients
  • Further Information (e.g., Links to Support Groups)

Perlman Syndrome – Diagnosis

Genetic Diagnostics

The diagnosis of “Perlman syndrome” is made clinically and confirmed by the detection of a DIS3L2 mutation by gene analysis.

Differential Diagnoses

Clinical Presentation

Characteristic features are polyhydramnios, macrosomia, characteristic facial features, renal dysplasia, nephroblastomatosis, and multiple congenital anomalies. More than 50% of those affected die of complications during the neonatal period, such as kidney failure, hypoxia, and pulmonary hypoplasia. The kidneys exhibit nephroblastomatosis in 75% of the cases. A developmental delay is common, and most of those who survive develop nephroblastomas, often on both sides.

Special Features of Treatment

The treatment should be administered by a multidisciplinary team.

Diagnosis of Perlman Syndrome- What's Next?

Once diagnosed, it is recommended that a cancer predisposition specialist manage the patient. The following section explains whether cancer screening tests or other measures are necessary and how they should be performed. Some additional information, including links to support groups, is also included at the end of this page.

Diagnosis of Perlman Syndrome- What's Next?

Once diagnosed, it is recommended that a cancer predisposition specialist manage the patient. The following section explains whether cancer screening tests or other measures are necessary and how they should be performed. Some additional information, including links to support groups, is also included at the end of this page.

Recommendations for Early Detection in Your Patients

  • An abdominal and renal ultrasound every 3 months until the age of 7 due to the increase risk of Wilms tumors

Perlman Syndrome – weitere Informationen

Open Clinical Trials/ Registries

Additional Resources

Unfortunately, we are currently not aware of any support groups for patients with Perlman Syndrome. New information will be added as soon as it becomes available.